This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Related letters  • Similar articles in JAMA  Topic Collections  • Journalology/ Peer Review/ Authorship  • Medical Ethics  • Neurology  • Alzheimer Disease  • Cognitive Disorders  • Statistics and Research Methods  • Drug Therapy, Other  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 144 words of the full text and any section headings.

To the Editor: The Editorial by Drs DeAngelis and Fontanarosa¹ makes valuable proposals on how to prevent medical publications from being turned into marketing tools by pharmaceutical and medical equipment companies. However, an author's declaration of financial dealings with industry is only meaningful if the monetary value received from each company over a preceding period (perhaps the past 2 years) is clearly stated.

Receiving $2000 for conference expenses carries different obligations and suggests a different relationship compared with receiving a $20 000 honorarium. To preserve personal privacy, the amount received could be declared in financial ranges, as is practiced by publicly listed companies when declaring personnel remuneration to shareholders in their annual report.

Increasing transparency in disclosure will clarify the actual financial interaction between authors and industry. This will lessen the chance that journal articles are subtly transformed into sponsored advertisements.

Financial Disclosures: None reported.

Hean T. Ong, MBBS
ongheanteik@gmail.com
H. T. Ong Heart Clinic
Penang, Malaysia

Jin S. Cheah, MBBS
Department of Medicine
National University of Singapore
Kent Ridge, Singapore

1. DeAngelis CD, Fontanarosa PB. Impugning the integrity of medical science: the adverse effects of industry influence. JAMA. 2008;299(15):1833-1835. FREE FULL TEXT

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2008;300(8):903-904.

RELATED ARTICLE

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
Catherine D. DeAngelis and Phil B. Fontanarosa
JAMA. 2008;299(15):1833-1835.
EXTRACT | FULL TEXT  

RELATED LETTERS

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Kent R. Johnson and Marissa N. D. Lassere
JAMA. 2008;300(8):900.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Garret A. FitzGerald
JAMA. 2008;300(8):900-901.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Carlo Patrono
JAMA. 2008;300(8):901.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Christopher J. Hawkey
JAMA. 2008;300(8):901.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Steven Ferris, Douglas Galasko, and Louis Kirby
JAMA. 2008;300(8):901-902.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Richard Balon
JAMA. 2008;300(8):902.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Serban-Dan Costa
JAMA. 2008;300(8):902-903.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Hervé Maisonneuve
JAMA. 2008;300(8):903.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies
Peter A. Lachenbruch and Ronald Wasserstein
JAMA. 2008;300(8):904.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Bruce M. Psaty and Richard A. Kronmal
JAMA. 2008;300(8):904.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Joseph S. Ross, David S. Egilman, and Harlan M. Krumholz
JAMA. 2008;300(8):904-905.
EXTRACT | FULL TEXT  

Guest Authorship, Mortality Reporting, and Integrity in Rofecoxib Studies—Reply
Catherine D. DeAngelis and Phil B. Fontanarosa
JAMA. 2008;300(8):905-906.
EXTRACT | FULL TEXT